Treatment of diseases caused by herpes viruses

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 3114

Patent

active

047600799

ABSTRACT:
This invention pertains to a method of treating diseases caused by Herpes Simplex Virus (HSV) Types 1 and 2. Disclosed herein is a method of treatment that, through the use of Tetraethylammonium Ion (TEA) achieves a selective and specific inhibition of viral function in diseases caused by HSV Types 1 and 2. TEA can be provided in the form of its chloride salt, unpreserved for individual doses, or with preservatives for multiple dose vials.

REFERENCES:
patent: 2295504 (1942-09-01), Shelton
patent: 2666009 (1954-01-01), Stayner
patent: 4262007 (1981-04-01), Sherrill
Physicians' Desk Reference, Sixth Ed., p. 491, Medical Economics Inc., Published (Rutherford, N.J.) (1952).
Blackwell et al., 57 J. Chem. Spec. Mfr. Ass., Proc. Ann. Meet., 103-106 (1971).
Kousoulas et al., 125 Virology, 468-74 (1983).
Holland et al., J. of Virol., 213-215 (Jul. 1977).
Moldenhauer, 29 Therapiewoche, 7344-.notident.(1977).
Koyama-A-Hajime, 138 Virology, 332-35 (1984).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of diseases caused by herpes viruses does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of diseases caused by herpes viruses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of diseases caused by herpes viruses will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-258173

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.